Isochromosome 17q in MDS: a marker of a distinct entity

Cancer Genetics and Cytogenetics

Volumn 166, Issue 2, 2006, Pages 189-190

  Pinheiro, Ronald Feitosa ^a   de Lourdes L F Chauffaille, Maria ^a   Silva, Maria Regina Régis ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AGED; BLOOD ANALYSIS; BLOOD SMEAR; CANCER DIAGNOSIS; CANCER MORTALITY; CASE REPORT; CELL HYPERPLASIA; CHROMOSOME 17Q; CHROMOSOME 7Q; CLINICAL EXAMINATION; DISEASE CLASSIFICATION; EOSINOPHILIA; GENE DELETION; GRANULOCYTE; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; ISOCHROMOSOME; LETTER; LEUKOCYTE DISORDER; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS; SCORING SYSTEM;

BONE MARROW; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 17; GENETIC MARKERS; HUMANS; ISOCHROMOSOMES; KARYOTYPING; MALE; MYELODYSPLASTIC SYNDROMES;

EID: 33646047136     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.10.004     Document Type: Letter

References (8)

1. Mitelman F. Catalog of chromosome aberrations in cancer. 5th ed. (1995), Wiley-Liss, New York. http://cgap.nci.nih.gov/Chromosomes/Mitelman [Quarterly updates available at http://cgap.nci.nih.gov/Chromosomes/Mitelman]
2. Fioretos T., Strömbeck B., Sandberg T., Johansson B., Billström R., Borg A., Nilsson P.G., Van den Berghe H., Hagemeijer A., Mitelman F., and Höglund M. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 94 (1999) 225-232
3. Marisavljevic D., Rolovic Z., Panitic M., Novak A., Djordjevic V., Lazarevic V., Boskovic D., and Colovic M. Chromosome 17 abnormalities in patients with myelodysplastic syndrome: incidence and biologic significance. [In Serbian]. Srp Arh Celok Lek 132 (2004) 10-13
4. Xiao Z., Liu S., Yu M., Xu Z., and Hao Y. Isochromosome 17q in patients with myelodysplastic syndromes: six new cases. Haematologica 88 (2003) 714-715
5. Sole F., Torrabadella M., Granada I., Florensa L., Vallespi T., Ribera J.M., Irriguible D., Milla F., and Woessner S. Isochromosome 17q as a sole anomaly: a distinct myelodysplastic syndrome entity?. Leuk Res 17 (1993) 717-720
6. McClure R.F., Dewald G.W., Hover J.D., and Hanson C.A. Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol 106 (1999) 445-454
7. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., Lister T.A., and Bloomfield C.D. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10 (1999) 1419-1432
8. Greenberg P., Cox C., LeBeau M.M., Fenaux P., Morel P., Sanz G., Sanz M., Vallespi T., Hamblin T., Oscier D., Ohyashiki K., Toyama K., Aul C., Mufti G., and Bennet J. International scoring system for evaluation prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088 [Erratum in: Blood 1998;91:1100]